المؤلفون: Julianne V. Kus, Carla Osiowy, Richard Garceau, Muhammad Morshed, Guillaume Desnoyers, Michael A. Drebot, Jonathan B. Gubbay, L. Robbin Lindsay, Michel Roger, Carmen L. Charlton, Bouchra Serhir, Denise Fudge, Ihssan Bouhtiauy, Vandana Mohan, Paul N. Levett, Vanessa Tran, Antonia Dibernardo, Nadia El-Gabalawy, Christian Therrien, George Zahariadis, Lei Jiao, Ainsley Gretchen, Robert Needle, Laura Gilbert, Derek R. Stein, Graham Tipples, Jamil N. Kanji, Inna Sekirov, Amanda Lang, Laurel Thorlacius, Jean Longtin

المصدر: Diagnostic Microbiology and Infectious Disease

مصطلحات موضوعية: 0301 basic medicine, Microbiology (medical), medicine.medical_specialty, Canada, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 030106 microbiology, Antibodies, Viral, Antibodies, Serology, Immunoenzyme Techniques, 03 medical and health sciences, 0302 clinical medicine, Environmental health, Pandemic, Medicine, Humans, Serologic Tests, 030212 general & internal medicine, Public health policy, Task force, business.industry, SARS-CoV-2, Public health, COVID-19, General Medicine, High-Throughput Screening Assays, Infectious Diseases, Sero-surveillance, Original Article, Enzyme immunoassays, Public Health, business, Laboratories

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da473106f5cddca2b7c6ddb387e4b95c
https://pubmed.ncbi.nlm.nih.gov/34425450